Table 1 Clinical characteristics of 95 mothers with SLE

Mean maternal age (yr, mean ± SD)

30.63 ± 4.09

Interval between diagnosis of SLE(yr, mean ± SD)

SLE active during Pregnancy

6.61 ± 4.84

44(46.3%)

Previous manifestations

Hematological disease

Cutaneous lesions

Articular disease

Renal disease

Serositis

Neuropsychiatric symptoms

22(23.2%)

8(8.4%)

7(7.4%)

42(44.2%)

4(4.2%)

0(0%)

Medication taking during pregnancy

Steroids

HCQ

Cytotoxic drugs

Aspirin

91(95.8%)

67(70.5%)

16(16.8%)

75(78.9%)

Positive antibodies at onset of pregnancy ^#

Anti-SSA/Ro

Anti-SSB/La

Anti-dsDNA

Anti-Sm

aPLs

45(47.9%)

10(10.6%)

55(57.4%)

7(7.4%)

5(5.3%)

Pregnancy complications

PE/E

GDM

PIH

HELLP

55(57.9%)

31(32.6%)

8(8.4%)

37(38.9%)

24(25.3%)

Delivery mode

Vaginal delivery

Cesarean delivery

8.4% (8)

91.6% (87)